Clinical Research

We produce research and build research capacity to increase the range of treatment options for people who use methamphetamine and emerging drugs. 

Learn more
Man therapy

Current Research Projects

View all projects
View all projects

Lisdexamfetamine for methamphetamine withdrawal: clinical trial

A clinical trial in Australia to test lisdexamfetamine as a treatment for methamphetamine withdrawal (the OLAM trial).

OLAM LOGO

S-Check App

A mobile app to understand and track methamphetamine use


 

S Check Logo

The IMPACT Study

A study examining a new internet delivered cognitive behavioural therapy program for Methamphetamine. IMPACT is now open for participants.

Impact study background
Friday 22nd November

2024 NCCRED Symposium

The 2024 NCCRED Symposium will discuss innovations within the alcohol and other drug sector which aim to improve the health outcomes for people who use methamphetamine and emerging drugs of concern.

Frame 1261161931

The Community Drug Reporting System

Confidentially share information about a drug-related experience or observation to keep community informed.

More Information
Quotation marks

Sign up to our mailing list

Stay up to date on our upcoming webinars

Sign up
Branching arrow

Emerging drugs resources

Webinars, videos, toolkits and reports to support clinicians to deliver better outcomes for people who use methamphetamine and emerging drugs. 

View resources
Home page resources card

Our consortium

Funded by the Commonwealth Department of Health, Disability and Ageing, NCCRED is made up of a consortium.

About us
Consortium